OrthogenRx, Inc., headquartered in the United States, is a pioneering company in the orthobiologics industry, specialising in innovative treatments for musculoskeletal conditions. Founded in 2014, OrthogenRx has rapidly established itself as a leader in the development of regenerative medicine solutions, particularly in the field of orthopaedics. The company’s flagship product, the Orthovisc® injection, is renowned for its unique formulation that provides effective relief for osteoarthritis patients. This product, along with their other offerings, showcases OrthogenRx's commitment to advancing patient care through cutting-edge technology and research. With a strong presence across major operational regions in the US, OrthogenRx has achieved significant milestones, including numerous clinical studies that underscore the efficacy of its products. The company continues to enhance its market position through a focus on quality and innovation, making it a trusted name in the orthobiologics sector.
We don't have data for OrthogenRx, Inc., but we can show you information about their parent organization instead.
View parent company